Datar Cancer Genetics Target-MRD
Datar Cancer Genetics has launched Target-MRD, an advanced molecular residual disease (MRD) monitoring blood test for solid organ cancers. The test uses both tumor-agnostic next-generation sequencing and tumor-informed, patient-customized droplet digital PCR.